Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK).


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
09 2022
Historique:
received: 19 04 2021
accepted: 09 09 2021
pubmed: 2 12 2021
medline: 20 8 2022
entrez: 1 12 2021
Statut: ppublish

Résumé

Risk factors for severe COVID-19 include older age, male sex, obesity, black or Asian ethnicity and underlying medical conditions. Whether these factors also influence susceptibility to developing COVID-19 is uncertain. We undertook a prospective, population-based cohort study (COVIDENCE UK) from 1 May 2020 to 5 February 2021. Baseline information on potential risk factors was captured by an online questionnaire. Monthly follow-up questionnaires captured incident COVID-19. We used logistic regression models to estimate multivariable-adjusted ORs (aORs) for associations between potential risk factors and odds of COVID-19. We recorded 446 incident cases of COVID-19 in 15 227 participants (2.9%). Increased odds of developing COVID-19 were independently associated with Asian/Asian British versus white ethnicity (aOR 2.28, 95% CI 1.33 to 3.91), household overcrowding (aOR per additional 0.5 people/bedroom 1.26, 1.11 to 1.43), any versus no visits to/from other households in previous week (aOR 1.31, 1.06 to 1.62), number of visits to indoor public places (aOR per extra visit per week 1.05, 1.02 to 1.09), frontline occupation excluding health/social care versus no frontline occupation (aOR 1.49, 1.12 to 1.98) and raised body mass index (BMI) (aOR 1.50 (1.19 to 1.89) for BMI 25.0-30.0 kg/m After rigorous adjustment for factors influencing exposure to SARS-CoV-2, Asian/Asian British ethnicity and raised BMI were associated with increased odds of developing COVID-19, while atopic disease was associated with decreased odds. ClinicalTrials.gov Registry (NCT04330599).

Sections du résumé

BACKGROUND
Risk factors for severe COVID-19 include older age, male sex, obesity, black or Asian ethnicity and underlying medical conditions. Whether these factors also influence susceptibility to developing COVID-19 is uncertain.
METHODS
We undertook a prospective, population-based cohort study (COVIDENCE UK) from 1 May 2020 to 5 February 2021. Baseline information on potential risk factors was captured by an online questionnaire. Monthly follow-up questionnaires captured incident COVID-19. We used logistic regression models to estimate multivariable-adjusted ORs (aORs) for associations between potential risk factors and odds of COVID-19.
RESULTS
We recorded 446 incident cases of COVID-19 in 15 227 participants (2.9%). Increased odds of developing COVID-19 were independently associated with Asian/Asian British versus white ethnicity (aOR 2.28, 95% CI 1.33 to 3.91), household overcrowding (aOR per additional 0.5 people/bedroom 1.26, 1.11 to 1.43), any versus no visits to/from other households in previous week (aOR 1.31, 1.06 to 1.62), number of visits to indoor public places (aOR per extra visit per week 1.05, 1.02 to 1.09), frontline occupation excluding health/social care versus no frontline occupation (aOR 1.49, 1.12 to 1.98) and raised body mass index (BMI) (aOR 1.50 (1.19 to 1.89) for BMI 25.0-30.0 kg/m
CONCLUSIONS
After rigorous adjustment for factors influencing exposure to SARS-CoV-2, Asian/Asian British ethnicity and raised BMI were associated with increased odds of developing COVID-19, while atopic disease was associated with decreased odds.
TRIAL REGISTRATION NUMBER
ClinicalTrials.gov Registry (NCT04330599).

Identifiants

pubmed: 34848555
pii: thoraxjnl-2021-217487
doi: 10.1136/thoraxjnl-2021-217487
doi:

Banques de données

ClinicalTrials.gov
['NCT04330599']

Types de publication

Clinical Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

900-912

Subventions

Organisme : Medical Research Council
ID : MR/V028367/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023241/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601463
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_13043
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K006525/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Hayley Holt (H)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Mohammad Talaei (M)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Matthew Greenig (M)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Dominik Zenner (D)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Jane Symons (J)

Jane Symons Media, London, UK.

Clare Relton (C)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Katherine S Young (KS)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Molly R Davies (MR)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Katherine N Thompson (KN)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Jed Ashman (J)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Sultan Saeed Rajpoot (SS)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Ahmed Ali Kayyale (AA)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Sarah El Rifai (S)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Philippa J Lloyd (PJ)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

David Jolliffe (D)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Olivia Timmis (O)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Sarah Finer (S)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Stamatina Iliodromiti (S)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Alec Miners (A)

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Nicholas S Hopkinson (NS)

National Heart and Lung Institute, Imperial College London, London, UK.

Bodrul Alam (B)

Edenfield Road Surgery, Rochdale, UK.

Graham Lloyd-Jones (G)

Department of Radiology, Salisbury District Hospital, Salisbury, UK.

Thomas Dietrich (T)

School of Dentistry, Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.

Iain Chapple (I)

School of Dentistry, Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.

Paul E Pfeffer (PE)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

David McCoy (D)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Gwyneth Davies (G)

Population Data Science, Swansea University Medical School, Swansea, UK.

Ronan A Lyons (RA)

Population Data Science, Swansea University Medical School, Swansea, UK.

Christopher Griffiths (C)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Frank Kee (F)

Centre for Public Health Research (NI), Queen's University Belfast, Belfast, UK.

Aziz Sheikh (A)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Gerome Breen (G)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Seif O Shaheen (SO)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Adrian R Martineau (AR)

Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK a.martineau@qmul.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH